rxstat › Shortages › Exenatide

Exenatide shortage status

Discontinued

Source: Health Canada shortage reports · Updated Jul 9, 2026

Exenatide products have been discontinued in Canada. See the reports below for which products and when.
Products affected
0 / 3
Reports on file
6

Reports by product

Discontinued
BYETTA
5MCG · SOLUTION · ASTRAZENECA CANADA INC
DIN 02361809
Discontinued
BYDUREON
2MG · KIT POWDER FOR SUSPENSION, EXTENDED-RELEASE · ASTRAZENECA CANADA INC
DIN 02448610
Discontinued
BYETTA
10MCG · SOLUTION · ASTRAZENECA CANADA INC
DIN 02361817
Resolved
BYETTA
250MCG · SOLUTION · ASTRAZENECA CANADA INC
DIN 02361817 · ended Apr 1, 2019 · Demand increase for the drug.
Resolved
BYETTA
250MCG · SOLUTION · ASTRAZENECA CANADA INC
DIN 02361817 · ended Sep 6, 2017 · Demand increase for the drug.
Resolved
BYETTA
250MCG · SOLUTION · ASTRAZENECA CANADA INC
DIN 02361817 · ended Jun 20, 2017 · Delay in shipping of the drug.

What's happening

One or more Exenatide products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.

Exenatide is classified under “BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS” (ATC A10BJ).

Recent changes

Common questions

When will Exenatide be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Exenatide in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (blood glucose lowering drugs, excl. insulins)

Widespread shortageCanagliflozin2 of 4 reported products affected · est. return Dec 4, 2026Widespread shortageSitagliptin12 of 24 reported products affected · est. return Jan 7, 2027Widespread shortageTirzepatide6 of 6 reported products affectedPartial shortageDapagliflozin4 of 11 reported products affected · est. return Jul 24, 2026Partial shortageDapagliflozin Metformin2 of 6 reported products affected · est. return Jul 24, 2026Partial shortageGliclazide2 of 20 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.